Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs MEDICO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM MEDICO REMEDIES NGL FINE CHM/
MEDICO REMEDIES
 
P/E (TTM) x 33.5 58.7 57.1% View Chart
P/BV x 5.8 9.3 62.0% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NGL FINE CHM   MEDICO REMEDIES
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
MEDICO REMEDIES
Mar-23
NGL FINE CHM/
MEDICO REMEDIES
5-Yr Chart
Click to enlarge
High Rs2,56987 2,954.6%   
Low Rs1,16116 7,258.4%   
Sales per share (Unadj.) Rs450.016.9 2,658.7%  
Earnings per share (Unadj.) Rs33.20.9 3,800.1%  
Cash flow per share (Unadj.) Rs51.41.2 4,284.4%  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs360.15.3 6,815.7%  
Shares outstanding (eoy) m6.1882.98 7.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.13.0 136.2%   
Avg P/E ratio x56.259.0 95.3%  
P/CF ratio (eoy) x36.342.9 84.5%  
Price / Book Value ratio x5.29.7 53.1%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m11,5234,272 269.8%   
No. of employees `000NANA-   
Total wages/salary Rs m36957 649.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,7811,404 198.0%  
Other income Rs m5541 135.4%   
Total revenues Rs m2,8361,445 196.2%   
Gross profit Rs m35095 368.7%  
Depreciation Rs m11327 415.0%   
Interest Rs m187 245.5%   
Profit before tax Rs m274101 270.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6929 240.3%   
Profit after tax Rs m20572 283.0%  
Gross profit margin %12.66.8 186.2%  
Effective tax rate %25.128.3 88.7%   
Net profit margin %7.45.2 142.9%  
BALANCE SHEET DATA
Current assets Rs m1,627662 245.8%   
Current liabilities Rs m583432 135.1%   
Net working cap to sales %37.516.4 229.0%  
Current ratio x2.81.5 182.0%  
Inventory Days Days653 2,485.0%  
Debtors Days Days865938 92.2%  
Net fixed assets Rs m1,244229 543.1%   
Share capital Rs m31166 18.6%   
"Free" reserves Rs m2,195272 805.5%   
Net worth Rs m2,225438 507.6%   
Long term debt Rs m212 839.3%   
Total assets Rs m2,871891 322.3%  
Interest coverage x15.914.5 109.6%   
Debt to equity ratio x00 165.3%  
Sales to assets ratio x1.01.6 61.4%   
Return on assets %7.89.0 86.7%  
Return on equity %9.216.5 55.8%  
Return on capital %13.024.6 52.8%  
Exports to sales %74.388.0 84.4%   
Imports to sales %9.98.6 115.2%   
Exports (fob) Rs m2,0661,236 167.1%   
Imports (cif) Rs m276121 228.2%   
Fx inflow Rs m2,0951,236 169.4%   
Fx outflow Rs m304124 244.7%   
Net fx Rs m1,7901,112 161.0%   
CASH FLOW
From Operations Rs m35382 432.1%  
From Investments Rs m-270-66 409.1%  
From Financial Activity Rs m-11-18 59.5%  
Net Cashflow Rs m72-3 -2,828.7%  

Share Holding

Indian Promoters % 73.1 73.3 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.3 3.1%  
FIIs % 0.0 1.3 3.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 26.7 101.1%  
Shareholders   16,410 6,052 271.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs MEDICO REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs MEDICO REMEDIES Share Price Performance

Period NGL FINE CHM MEDICO REMEDIES S&P BSE HEALTHCARE
1-Day -1.06% -0.47% 1.18%
1-Month 2.44% -43.31% -0.75%
1-Year 76.61% -36.23% 61.82%
3-Year CAGR 9.65% 108.16% 18.16%
5-Year CAGR 35.23% 61.34% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the MEDICO REMEDIES share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of MEDICO REMEDIES the stake stands at 73.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of MEDICO REMEDIES .

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

MEDICO REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of MEDICO REMEDIES .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.